ERAXIS 100 mg/30mL

ERAXIS 100 mg/30mL is an antifungal medication used to treat serious fungal infections. This lyophilized powder for injection contains anidulafungin, a key agent in managing invasive candidiasis and esophageal candidiasis.

ERAXIS 100 mg/30mL is primarily used for the treatment of invasive candidiasis and esophageal candidiasis. This antifungal injection is designed to combat fungal infections in patients who require intravenous therapy. Anidulafungin, the active ingredient, works by targeting the fungal cell wall, making it effective in managing these conditions.

Common effects of ERAXIS 100 mg/30mL may include infusion-related reactions such as fever, chills, and rash. Some patients might experience gastrointestinal issues like nausea or diarrhea. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

ERAXIS 100 mg/30mL should be handled with care, ensuring proper reconstitution and administration by trained healthcare professionals. Patients with known allergies to anidulafungin or similar antifungal agents should avoid this medication. Always follow the prescribed guidelines for storage and usage to maintain efficacy and safety.

ERAXIS 100 mg/30mL may interact with certain medications, particularly those metabolized by the liver. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol and other substances that affect liver function should be used cautiously.